BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37960223)

  • 1. Leucine Supplementation Exacerbates Morbidity in Male but Not Female Mice with Colorectal Cancer-Induced Cachexia.
    Schrems ER; Haynie WS; Perry RA; Morena F; Cabrera AR; Rosa-Caldwell ME; Greene NP; Washington TA
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine Supplementation in Cancer Cachexia: Mechanisms and a Review of the Pre-Clinical Literature.
    Beaudry AG; Law ML
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
    Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
    Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
    Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
    Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.
    Velázquez KT; Enos RT; Narsale AA; Puppa MJ; Davis JM; Murphy EA; Carson JA
    J Nutr; 2014 Jun; 144(6):868-75. PubMed ID: 24759931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in skeletal muscle alterations in a model of colorectal cancer.
    Greenman AC; Albrecht DM; Halberg RB; Diffee GM
    Physiol Rep; 2020 Mar; 8(5):e14391. PubMed ID: 32170841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats.
    Viana LR; Chiocchetti GME; Oroy L; Vieira WF; Busanello ENB; Marques AC; Salgado CM; de Oliveira ALR; Vieira AS; Suarez PS; de Sousa LM; Castelucci BG; Vercesi AE; Consonni SR; Gomes-Marcondes MCC
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-leucine dietary supplementation modulates muscle protein degradation and increases pro-inflammatory cytokines in tumour-bearing rats.
    Cruz B; Oliveira A; Gomes-Marcondes MCC
    Cytokine; 2017 Aug; 96():253-260. PubMed ID: 28494385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP12 knockout prevents weight and muscle loss in tumor-bearing mice.
    Jiang L; Yang M; He S; Li Z; Li H; Niu T; Xie D; Mei Y; He X; Wei L; Huang P; Huang M; Zhang R; Wang L; Li J
    BMC Cancer; 2021 Dec; 21(1):1297. PubMed ID: 34863141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle function during the progression of cancer cachexia in the male Apc
    VanderVeen BN; Hardee JP; Fix DK; Carson JA
    J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
    Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
    J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
    van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
    Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
    Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
    J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
    White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.
    Wyart E; Hsu MY; Sartori R; Mina E; Rausch V; Pierobon ES; Mezzanotte M; Pezzini C; Bindels LB; Lauria A; Penna F; Hirsch E; Martini M; Mazzone M; Roetto A; Geninatti Crich S; Prenen H; Sandri M; Menga A; Porporato PE
    EMBO Rep; 2022 Apr; 23(4):e53746. PubMed ID: 35199910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a leucine-supplemented diet on body composition changes in pregnant rats bearing Walker 256 tumor.
    Ventrucci G; Mello MA; Gomes-Marcondes MC
    Braz J Med Biol Res; 2001 Mar; 34(3):333-8. PubMed ID: 11262583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic or xenograft colorectal cancer models induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting in a tumor-type-dependent manner.
    Kim HG; Huot JR; Pin F; Belcher DJ; Bonetto A; Nader GA
    J Appl Physiol (1985); 2022 Dec; 133(6):1273-1283. PubMed ID: 36201323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.